Odyssey Therapeutics (ODTX) Earnings Yield: History & Chart

Odyssey Therapeutics, Inc.(ODTX)

Biotechnology · Boston, MA

$18.77-2.07 (-9.93%)

Delayed quote: Oct 6, 2026, 2:00 PM EDT

About Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering and developing novel treatments for autoimmune and inflammatory diseases. Its diverse pipeline features several key drug candidates: OD-001, an oral small molecule that inhibits receptor-interacting protein kinase 2, which is currently in Phase 2a clinical trials for ulcerative colitis. Also included is OD-002, an oral small molecule SLC15A4 inhibitor engineered to prevent harmful inflammatory responses driven by TLR7/8/9-mediated activation of interferon regulatory factor 5 (IRF5). Another program, OD-003, is a protein therapeutic designed to selectively agonize tumor necrosis factor receptor 2 on T regulatory cells. Further assets in its portfolio comprise a bispecific antagonist targeting TSLP and IL-33, an oral small molecule functioning as an interleukin-1 receptor-associated kinase 4 scaffolding inhibitor, and a separate small molecule inhibitor specifically targeting IRF5. The company was founded in 2021 and is headquartered in Boston, Massachusetts.

Boston, MA

100 employees

odysseytx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Gary D. Glick

View full financials

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Odyssey Therapeutics, Inc. (ODTX)	$901.55M	N/A	N/A	N/A	N/A
HealthStream, Inc. (HSTM)vs ›	$913.78M	2.29%	2.73%	2.26%	1.85%
Bioventus Inc. (BVS)vs ›	$899.02M	5.80%	3.29%	3.29%	3.62%
MoonLake Immunotherapeutics (MLTX)vs ›	$927.47M	N/A	N/A	N/A	N/A
CeriBell, Inc. (CBLL)vs ›	$932.06M	N/A	N/A	N/A	N/A
Kura Oncology, Inc. (KURA)vs ›	$939.11M	N/A	N/A	N/A	N/A
Arbutus Biopharma Corp (ABUS)vs ›	$877.52M	17.57%	17.36%	17.36%	17.36%
Seaport Therapeutics, Inc. Common Stock (SPTX)vs ›	$946.27M	N/A	N/A	N/A	N/A
Corvus Pharmaceuticals, Inc. (CRVS)vs ›	$868.65M	N/A	2.57%	2.57%	2.57%
Savara Inc. (SVRA)vs ›	$948.81M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EARNINGS YIELD

TTM

Odyssey Therapeutics, Inc. (ODTX)

$901.55M

N/A

HealthStream, Inc. (HSTM)vs ›

$913.78M

2.29%

2.73%

2.26%